Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients
ConclusionMetformin has no influence on the risk of UBC compared to SU in type 2 diabetes patients using a new‐user design. This article is protected by copyright. All rights reserved.
Source: British Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Maria E. Goossens, Frank Buntinx, Maurice P. Zeegers, J. H. M. Driessen, Marie L. De Bruin, Frank Vries Tags: Pharmacoepidemiology Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Fortamet | Insulin | Metformin | Oral Cancer | Smokers | Statistics | Study